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ABSTRACT 
We demonstrated a simple, highly efficient, one-pot method to 
construct triazolo/benzimidazolo quinazolinones through a cascade of 
oxidation, Knoevenagel condensation, and Michael addition followed 
by cyclization and dehydration. This protocol tolerates easily available 
benzyl halides, 2-amino benzimidazole/3-amino-1,2,4-triazole, and 
α-hydroxy C-H acids as starting materials using trimethyl amine 
N-oxide in ethanol. To the best of our knowledge, this is the first 
example of synthesis of triazolo/benzimidazolo quinazolinones 
directly from benzyl halides in one pot. Simple procedure, environ-
mental friendliness, mild reaction conditions, and good yields are the 
attractive features of this method.  
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trimethyl amine N-oxide  
Introduction 
Multicomponent reactions (MCRs) have been refined in recent years as powerful and 
necessary tools in synthetic organic and medicinal chemistry. This powerful tool combines 
both the environmental and economic aspects of organic chemistry that are essential for 
industrial and academic applications. MCRs offer remarkable advantages such as conver-
gence, reduction in the amount of workup, operational simplicity in the separation and 
purification processes, minimal waste production, and green transformations.[1–5] 
The synthesis of quinazolinone analogs is a significant synthetic reaction in organic 
chemistry as these scaffolds are found to be very important core structures in various 
natural products[6,7] and a wide range of biologically active synthetic compounds.[8,9] Many 
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commercially available drugs (Fig. 1) including ispinesib (anticancer), dacomitinib 
(anticancer), methaqualone (antimalarial), albaconazole (antifungal activity), balaglitazone 
(antidiabetic and hypolipidimic property), and anagrelide (for the treatment of essential 
thrombocytosis) are derived from quinazolinone core entities.[10] Quinazolinone moieties 
exhibit a variety of biological activities such as antitumor,[11] antiviral,[12] anticancer,[13] 
antileishmanial,[14] antimicrobial,[15] anti-inflammatory,[16] antitubercular,[17] antimalar-
ial,[18] antifungal,[19] and antibiotic.[20] Hence, the synthesis of quinazolinone has evoked 
much interest, as a result of which a variety of synthetic methodologies have been 
reported.[21–23] The most important approaches are (i) one-pot condensation of aromatic 
aldehydes, 2-amino benzimidazole/3-amino-1,2,4-triazole, and α-hydroxy C-H acids,[24] 
(ii) three-component reaction of 2-amino benzamides, aryl halides, and isocyanides,[25] 
(iii) one-pot reaction with o-amino benzamides and primary alcohols,[26] (iv) cascade 
synthesis of phenylamino substituted quinazolinones from urea derivatives and tert-butyl 
isocyanide,[27] [v] oxidative radical skeletal rearrangement induced by oxygen,[28] (vi) 
synthesis of quinazolinone and quinazoline from aerobic oxidative C(sp3)  H amination/ 
C  N cleavage.[29] Other methods have also been developed within the past three 
decades.[30] In the past years, a few methods have described the one-pot multicomponent 
synthesis of quinazolinones based on catalysts such as NH2SO3H,[31] thiamine hydro-
chloride,[32] CuCl,[33] chitosan,[34] nafion-H,[35] Mg-Al-CO3,[36] silica gel,[37] and 
H6P2W18O6 · 18H2O[38] from the reaction of aromatic aldehydes, 2-amino benzimidazole/ 
3-amino-1,2,4-triazole, and α-hydroxy C-H acids. Nevertheless, these methods may be 
restricted to benzaldehyde and have some significant limitations, such as harsh reaction 
conditions, long reaction time, tedious workup, poor yields, and use of metal- and moist-
ure-sensitive catalysts. Hence, the development of a simple, high-yielding, and environ-
mentally kind procedure for the one-pot multicomponent synthesis of quinazolinone 
analogs is still reasonable. 
As part of our continuing efforts on the development of new methods for the 
construction of biologically active compounds,[39] we have reported synthesis of 
Figure 1. Quinazolinone-derived commercially available drugs.  
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pyran-based heterocycles via one-pot reaction of benzyl halides, α-hydroxy C-H acids, and 
active methylene compounds.[40] Herein, we investigated a new and straightforward 
approach for the synthesis of triazolo/benzimidazolo quinazolinones that involved an in 
situ oxidation of benzyl halides with trimethyl amine N-oxide into corresponding 
aldehydes, which they undergo a three-component reaction with α-hydroxy C-H acids 
and 2-aminobenzimidazole/3-amino-1,2,4-triazole without addition of any other catalyst. 
The wider scope and synthetic utility of trimethyl amine N-oxide for the synthesis of 
heterocyclic compounds in one pot has not been explored even though this reagent has 
been used as an oxidizing agent.[41,42] This procedure developed the known reaction using 
the novel methodology, while not limiting one of the substrates to an aldehyde.[43] 
Results and discussion 
To set up the optimal reaction conditions for the construction of quinazolinone analogs, 
our preliminary experiments were focused on a one-pot reaction involving 3-cyanobenzyl 
bromide (1 equiv), 2-amino benzimidazole (1 equiv), and dimidone (1 equiv) in the 
presence of trimethyl amine N-oxide (2 equiv) as an oxidizing agent. For a low-hazard 
and ecofriendly process, ethanol is used as a preferred solvent for all the optimization 
experiments. The reactions were performed with heating at 70 °C. The yield of the product 
was relatively superior. However, the yield decreased when the reaction proceeded to room 
temperature or more than 70 °C. Based on these results, a reaction of 3-cyanobenzyl 
bromide (1 equiv), 2-amino benzimidazole (1 equiv), and dimidone (1 equiv) in the 
presence of trimethyl amine N-oxide (2 equiv) stirring in ethanol at 70 °C was considered 
as a standard and model reaction (Scheme 1) to optimize the reaction conditions for the 
one-pot synthesis of other triazolo/benzimidazolo quinazolinones.[44] 
To evaluate the effect of organic solvents to optimize the reaction conditions using 
trimethyl amine N-oxide as an oxidizing agent for the synthesis of quinazolinone analogs 
(Table 1), ethanol was replaced with other polar solvents such as tetrahydrofuran (THF), 
acetonitrile, dimethylformamide (DMF), water, acetic acid, and methanol (entries 4 and 
6–10). The results showed that using ethanol as the solvent gave the best yield of the 
respective product with greater reaction rate (entry 5). The use of nonpolar solvents such 
as toluene, chloroform, and dioxane afforded the desired product in traces (entries 1–3). 
Therefore, ethanol was selected as a suitable medium to run the further reaction. 
The scope of the present protocol was further investigated by the replacement of 
dimidone with ethylacetoacetate. To our observation, the reaction underwent successful 
Scheme 1. Synthesis of 12(3-cyanophenyl)-3,3-dimethyl-1,2,3,4,5,12-hexahydrobenzo[4,5]imidazo 
[2,1-b]quinazolin-1-one (4a).  
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condensation under similar reaction conditions to give the corresponding quinazolinone 
analogs in excellent yields (Table 2, entries 8 and 9). Reactions were also carried out by 
replacing 2-amino benzimidazole with 3-amino-1,2,4-triazole. The reaction underwent 
smooth cyclization to give respective quinazolinone derivatives in virtually good yields 
(Table 2, entries 10–14). Thereafter, a series of different substituted quinazolinone analogs 
were synthesized from different benzyl halides containing electron-withdrawing and 
electron-donating groups using trimethyl amine N-oxide in ethanol at 70 °C in good 
yields[45] (Table 2). In general, the overall yield ranged from 96%  for 3,3-dimethyl- 
12(4-nitro-phenyl)-1,2,3,4,5,12-hexahydrobenzo[4,5]imidazo[2,1-b]quinazolin-1-one (4h) 
(entry 8) to 85%  for 6,6-dimethyl-9-(4-hydroxy-phenyl)-5,6,7,9-tetrahydro-4H-1,2,4- 
triazolo[5,1-b] quinazolin-8-one (4m) (entry 13). 
The proposed mechanism (Scheme 2) is similar to the well-known mechanism reported 
in the literature.[46–49] In the first step, oxidation proceeds via nucleophilic substitution of 
the benzyl halide with the oxygen of the trimethyl amine N-oxide to give a N-alkoxy salt. 
Afterward, proton elimination at the carbon carrying the oxygen leads to the formation of 
an aldehyde, giving trimethyl amine hydrogen halide salt, which in the second step would 
able to acid catalyze Knoevenagel condensation between aldehyde and α-hydroxy C-H acid 
to give the heterodiene. The third step is the Michael addition of the amino compound on 
the heterodiene, followed by cyclization and dehydration in the presence of acid to afford 
the desired product. 
Conclusion 
In conclusion, we have developed a new and straightforward methodology for the one-pot 
synthesis of quinazolinone analogs via trimethyl amine N-oxide–catalyzed in situ oxidation 
of benzyl halides into benzaldehydes followed by the three-component reaction with 
α-hydroxy C-H acids and amine compounds. Mild reaction condition, one-pot operation, 
easy isolation of product, and broad functional group tolerance are the main advantages of 
this reaction. 
Experimental 
All the reagents were purchased commercially and were used directly without further 
purification. The melting points were measured by the open capillary tubes using 
electric melting-point equipment and are uncorrected. The infrared (IR) spectra were 
obtained using an Agilent Cary 630 FT-IR spectrophotometer. 1H NMR (400 MHz) 
Table 1. Optimization of solvents for the synthesis (4a). 
Entry Solvent Time (min) Yield (%)  
1 Toluene 95 Trace 
2 CHCl3 95 Trace 
3 Dioxane 90 Trace 
4 THF 80 55 
5 Ethanol 70 96 
6 Acetonitrile 75 86 
7 DMF 80 78 
8 Water 80 68 
9 Acetic acid 80 65 
10 Methanol 70 70  



















































































































































































































































































































































































































































































































































































and 13C NMR (100 MHz) spectra were recorded on a Bruker spectrometer using 
dimethylsulfoxide (DMSO-d6) as solvents and tetramethylsilane (TMS) as an internal 
standard at IISC, Bangalore. The chemical shifts were given on the δ scale (ppm). 
The purity of the compounds was checked by thin-layer chromatography (TLC, Merck 
silica-gel 60 F254 precoated aluminium sheets). The CHN analysis was performed on an 
Elemental Vario Micro Cube CHN rapid analyzer. All the synthesized compounds gave 
agreeable elemental study results. 
Typical procedure for the synthesis of 12(3-cyanophenyl)-3,3-dimethyl- 
1,2,3,4,5,12-hexahydrobenzo[4,5]imidazo[2,1-b]quinazolin-1-one (4a) 
Trimethyl amine N-oxide (290 mg, 3.0 mmol) was added to a solution of 3-cyanobenzyl 
bromide (290 mg, 1.5 mmol), dimidone (210 mg, 1.5 mmol), and 2-aminobenzimidazole 
(200 mg, 1.5 mmol) in ethanol (10 mL) in a round-bottomed flask. The resulting reaction 
mixture was heated at 70 °C in an oil bath for 70 min. The progress of the reaction was 
monitored by TLC. After completion of the reaction, the reaction mixture was allowed 
to cool to room temperature. The solid was collected by filtration at pump, washed with 
ethanol, and recrystallized from hot ethanol to obtain pure product. 
12(3-Cyano-phenyl)-3,3-dimethyl-1,2,3,4,5,12-hexahydrobenzo[4,5]imidazo[2,1- 
b]quinazolin-1-one (4a) 
Yield 94%; white solid; mp > 300 °C; IR (ATR, cm  1): 3394 (NH), 2018 (CN), 1660 
(C=O) cm  1; 1H NMR (400 MHz, DMSO-d6): δ 0.98 (s, 3H, -CH3), 1.04 (s, 3H, -CH3), 
Scheme 2. Plausible reaction mechanism for the formation of quinazolinone derivatives.  
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2.22 (m, J ¼ 4.0 Hz, 2H, -CH2), 2.48–2.64 (m, J ¼ 4.0 Hz, 2H, -CH2,), 6.50 (s, 1H, CH), 
6.94–7.92 (m, 8H, Ar-H), 11.18 (s, 1H, NH) ppm; 13C NMR (100 MHz, DMSO-d6): 
δ 26.7, 28.1, 28.4, 32.2, 49.7, 53.6, 105.3, 109.9, 111.0, 117.0, 118.5, 120.7, 122.0, 129.8, 
130.9, 131.5, 141.8, 142.8, 145.0, 150.9, 158.1, 159.1, 192.6 ppm. Anal. calcd. for 
C23H20N4O: C, 74.98; H, 5.47; N, 15.21. Found: C, 74.82; H, 5.31; N, 15.13. 
Funding 
We acknowledge a grant from the Department of Science and Technology–Science Engineering 
Research Board (DST-SERB), New Delhi, India, under Fast Track Young Scientist Scheme [Grant 
No. SB/FT/CS-028/2013]. 
References  
[1] Gu,Y. Green Chem. 2012, 14, 2091.  
[2] Wei, E.; Liu, B.; Lin, S.; Liang, F. Org. Biomol. Chem. 2014, 12, 6389.  
[3] Nourisefat, M.; Panahi, F.; Nezhad, A. K. Org. Biomol. Chem. 2014, 12, 9419.  
[4] Shivashankar, K.; Shastri, L. A.; Kulkarni, M. V.; Rasal, V.P.; Saindane, D. M. J. Indian Chem. 
Soc. 2009, 86, 265.  
[5] Pereira, M. F.; Thiery, V. Org. Lett. 2012, 14, 4754.  
[6] Liu, F.; Kaselj, M.; Isome, Y.; Ye, P.; Sargent, K.; Sprague, K.; Cherrak, D.; Wilson, C. J.; Si, Y.; 
Yohannes, D.; Ng, S. C. J. Comb. Chem. 2006, 8, 7.  
[7] Sawant, S. D.; Srinivas, M.; Reddy, G. L.; Rao, V. V.; Singh, P. P.; Vishwakarma, R. A. 
Tetrahedron Lett. 2012, 53, 6195.  
[8] Khan, I.; Ibrar, A.; Abbas, N.; Saeed, A. Eur. J. Med. Chem. 2014, 76, 193.  
[9] Rajput, R.; Mishra, A. P. Int. J. Pharm. Sci. 2012, 4, 66. 
[10] (a) Vijayakumar, B.; Prasanthi, P.; Teja, K. M.; Reddy, K. M. K.; Nishanthi, P.; Nagendramma, 
M.; Nishanthi, M. Int. J. Med. Chem. Anal. 2013, 3, 10; (b) Asif, M. Int. J. Med. Chem. 2014, 
2014, 1; (c) Baltork, I. M.; Khosropour, A. R.; Moghadam, M.; Tangestaninejad, S.; Mirkhani, 
V.; Baghersad, S.; Mirjafari, A. C. R. Chim. 2011, 14, 944; (d) Selvam, T. P.; Kumar, P. V. Res. 
Pharm. 2011, 1, 1. 
[11] Bayouki, K. A. M. E.; Aly, M. M.; Mohamed, Y. A.; Basyouni, W. M.; Abbas, S. Y. World J. 
Chem. 2009, 4, 1619; (b) Obaid, A. M. A.; Hamide, S. G. A.; Kashef, H. A. E.; Aziz, A. A. 
M. A.; Azab, A. S. E.; Khamees, H. A. A.; Subbagh, H. I. E. Eur. J. Med. Chem. 2009, 44, 2379. 
[12] (a) Ma, J.; Li, P.; Li, X.; Shi, Q.; Wan, Z.; Hu, D.; Jin, L.; Song, B. J. Agric. Food. Chem. 2014, 62, 
8928; (b) Wang, Z.; Wang, M.; Yao, X.; Li, Y.; Tan, J.; Wang, L.; Qiao, W.; Geng, Y.; Liu, Y.; 
Wang, Q. Eur. J. Med. Chem. 2012, 53, 275. 
[13] Noolvi, M. N.; Patel, H. M.; Bhardwaj, V.; Chauhan, A. Eur. J. Med. Chem. 2011, 46, 2327; (b) 
Zhang, G. H.; Xue, W. B.; An, Y. F.; Yuan, J. M.; Qin, J. K.; Pan, C. X.; Su, G. F. Eur. J. Med. 
Chem. 2015, 95, 377; (c) Kamal, A.; Bharathi, E. V.; Ramaiah, M. J.; Dastagiri, D.; Redd, J. S.; 
Viswanath, A.; Sultana, F.; Pushpavalli, S. N. C. V. L.; Bhadra, M. P.; Srivastava, H. K.; Sastry, G. 
N.; Juvekar, A.; Sen, S.; Zingde, S. Bioorg. Med. Chem. 2010, 18, 526. 
[14] Sharma, M.; Chauhan, K.; Shivahare, R.; Vishwakarma, P.; Suthar, M. K.; Sharma, A.; Gupta, S.; 
Saxena, J. K.; Lal, J.; Chandra, P.; Kumar, B.; Chauhan, P. M. S. J. Med. Chem. 2013, 56, 4374. 
[15] Pandey, S. K.; Singh, A.; Singh, A.; Nizamuddin. Eur. J. Med. Chem. 2009, 44, 1188; (b) Desai, 
N. C.; Vaghani, H. V.; Shihora, P. N. J. Fluorine. Chem. 2013, 53, 39. 
[16] Chandrika, P. M.; Rao, A. R. R.; Narsaiah, B.; Raju, M. B. Int. J. Chem. Sci. 2008, 66, 1119; 
(b) Nanthakumar, R.; Muthumani, P.; Girija, K. Arabian. J. Chem. 2014, 53, 1049. 
[17] (a) Lu, W.; Baig, I. A.; Sun, H. J.; Cui, C. J.; Guo, R.; Jung, I. P.; Wang, D.; Dong, M.; Yoon, M. 
Y.; Wang, J. G. Eur. J. Med. Chem. 2015, 94, 298; (b) Rashmi, A.; Ashish, K.; Gill, N. S.; Rana, A. 
C. Int. J. Pharm. 2011, 2, 22. 
[18] Havaldar, F. H.; Patil, A. R. E-J. Chem. 2008, 5, 347. 
SYNTHETIC COMMUNICATIONS® 431 
[19] Wang, X.; Li, P.; Li, Z.; Yin, J.; He, M.; Xue, W.; Chen, Z.; Song, B. J. Agric. Food. Chem. 2013, 
61, 9575. 
[20] Bouley, R.; Kumarasiri, M.; Peng, Z.; Otero, L. H.; Song, W.; Suckow, M. A.; Schroeder, V. A.; 
Wolter, W. R.; Lastochkin, E.; Antunes, N. T.; Pi, H.; Serge, V. A.; Vakulenko, S.; Hermoso, 
J. A.; Chang, M.; Mobashery, S. J. Am. Chem. Soc. 2015, 137, 17381. 
[21] Patil, D. A.; Patil, P. O.; Deshmukh, P. K.; Patil, G. B.; Shewale, B. D.; Patil, D. D.; Gattani, S. G. 
Res. J. Pharm. Tech. 2010, 4, 979. 
[22] Connolly, D. J.; Cusack, D.; Sullivan, T. P. O.; Guiry, P. J. Tetrahedron 2005, 6, 10153. 
[23] Mhaske, S. B.; Argade, N. P. Tetrahedron 2006, 62, 9787. 
[24] Mourad, A. E.; Aly, A. A.; Farag, H. H.; Beshr, E. A. Beilstein. J. Org. Chem. 2007, 3, 1. 
[25] Jiang, X.; Tang, T.; Chen, J. Z.; Zhu, Y.; Ji, S. J. Org. Chem. 2014, 79, 5082. 
[26] Zhou, J.; Fang, J. J. Org. Chem. 2011, 76, 7730. 
[27] Sharma, S.; Jain, A. Tetrahedron Lett. 2014, 55, 6051. 
[28] Wang, Y. F.; Zhang, F. L.; Chiba, S. Org. Lett. 2013, 15, 2842. 
[29] Yan, Y.; Xu, Y.; Niu, B.; Xie, H.; Liu, Y. J. Org. Chem. 2015, 80, 5581. 
[30] Wang, D.; Gao, F. Chem. Cent. J. 2013, 7, 1. 
[31] Heravi, M. M.; Derikvand, F.; Ranjbar, L. Synth. Commun. 2010, 40, 677. 
[32] Liu, J.; Lei, M.; Hu, L. Green Chem. 2012, 14, 840. 
[33] Chen, Z.; Chen, J. M.; Liu, J.; Ding, W.; Gao, X.; Wu, H. J. Org. Chem. 2013, 78, 11342. 
[34] Sahu, P. K.; Sahu, P. K.; Gupta, S. K.; Agarwal, D. D. Ind. Eng. Chem. Res. 2014, 53, 2085. 
[35] Kidwai, M.; Chauhan, R. J. Mol. Catal. A: Chem. 2013, 377, 1. 
[36] Sahu, P. K.; Sahu, P. K.; Jain, R.; Yadava, R.; Agarwal, D. D. Catal. Sci. Technol. 2012, 2, 2465. 
[37] Krishnamurthy, G.; Jagannath, K. V. J. Chem. Sci. 2013, 125, 807. 
[38] Heravi, M. M.; Ranjbar, L.; Derikvand, F.; Alimadadi, B.; Oskooie, H. H.; Bamoharram, F. F. 
Mol. Divers. 2008, 12, 181. 
[39] (a) Puttaraju, K. B.; Shivashankar, K.; Chandra, Mahendra, M.; Rasal, V. P.; Vivek, P. N. V.; Rai, 
K.; Chanu, M. B. Eur. J. Med. Chem. 2013, 69, 316; (b) Puttaraju, K. B.; Shivashankar, K. RSC 
Adv. 2013, 3, 20883; (c) Jagadishbabu, N.; Shivashankar, K. RSC Adv. 2015, 5, 95240. 
[40] Beerappa, M.; Shivashankar, K. RSC Adv. 2015, 5, 30364. 
[41] Godfrey, A. G.; Ganem, B. Tetrahedron Lett. 1990, 31, 4825. 
[42] Zheng, P.; Yan, L.; Ji, X.; Duan, X. Synth. Commun. 2010, 41, 16. 
[43] Adib, M.; Sheikhi, E.; Rezaei, N. Tetrahedron Lett. 2011, 52, 3191. 
[44] Keyume, A.; Esmayil, Z.; Wang, L.; Jun, F. Tetrahedron 2014, 70, 3976. 
[45] Khurana, J. M.; Nand, B.; Saluja. P. Tetrahedron 2010, 66, 5637. 
[46] Khumraksa, K.; Phakhodee, W.; Pattarawarapan, M. Tetrahedron Lett. 2013, 54, 1983. 
[47] Barbry, D.; Champagne, P. Tetrahedron Lett. 1996, 37, 7725. 
[48] Puligoundla, R. G.; Karnakanti, S.; Bantu, R.; Kommu, N.; Kondra, S. B.; Nagarapu, L. 
Tetrahedron Lett. 2013, 54, 2480. 
[49] Alinezhad, H.; Tajbakhsh, M.; Norouzi, M.; Baghery, S.; Akbari M. C. R. Chim. 2014, 17, 7. 
[50] Shao, Q.; Tu, S.; Li, C.; Cao, L.; Zhou, D.; Wang, Q.; Jiang, B.; Zhang, Y.; Hao, W. J. Heterocycl. 
Chem. 2008, 45, 411. 
[51] Yao, C.; Lei, S.; Wang, C.; Li, T.; Yu, C.; Wang, X.; Tu, S. J. Heterocycl. Chem. 2010, 47, 26.  
432 M. BEERAPPA AND K. SHIVASHANKAR 
